NL-OMON25981已完成不适用
Can the use of the PPAR-gamma agonist rosiglitazon reverse the abnormal distribution of fat, as well as disturbances in glucose and lipid metabolism in HIV-associated lipodystrophy syndrome?
Academic medical centre, Dept of endocrinology and metabolism, F5-170, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •2. age>18 years;
排除标准
- •1. Active hepatitis;
- •2. ALAT/ASAT>2.5x above normal level;
研究者
相似试验
已完成
不适用
Pioglitazone and Losartan Provides Additional RenoprotectionType 2 DiabetesDiabetic NephropathyNCT00364988Shanghai Jiao Tong University School of Medicine60
进行中(未招募)
不适用
Clinical role of PPAR gamma activator (pioglitazone) in reducing the gastric phlogosis in patiens with istological gastritis.Treatment of patients with gastric phlogosis (infected by Helicobacter pylori)MedDRA version: 9.1Level: LLTClassification code 10017904Term: Gastroenteritis helicobacterEUCTR2005-001218-42-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
4 期
Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular DysfunctionDiabetes Mellitus, Type 2NCT00300911Baskent University45
进行中(未招募)
1 期
Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects - PioglitazoneThere is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the development of atherosclerosis, hypertension and heart failure. Endothelial dysfunction can occur even in the vascular absence of angiographically defined disease and can be detected early in the spectrum of insulin resistance.EUCTR2004-003861-34-ATDepartment of Nuclear Medicine62
尚未招募
2 期
The effect of Rosiglitazone in the treatment of depressioIRCT20090117001556N152Tehran University of Medical Sciences50
